Cardiovascular disease in diabetics: pharmacology and revascularization.
Publication/Presentation Date
11-1-2004
Abstract
Diabetes has become a public health crisis. With the incidence of obesity rising in the United States, the number of diabetics will grow considerably. Of greatest concern is the impact this trend will have on cardiovascular disease. Diabetics demonstrate accelerated coronary atherosclerosis, and the prognosis is worse following cardiac events. Moreover, our interventions have achieved uneven success in treating this subset of patients. This paper will review the metabolic abnormalities that promote atherosclerosis in diabetics and the current methods for treating and preventing the development of coronary artery disease in diabetics, principally through a combination of medications and revascularization.
Volume
71
Issue
6
First Page
375
Last Page
383
ISSN
0027-2507
Published In/Presented At
Mangalmurti, S. S., & Farkouh, M. E. (2004). Cardiovascular disease in diabetics: pharmacology and revascularization. The Mount Sinai journal of medicine, New York, 71(6), 375–383.
Disciplines
Medicine and Health Sciences
PubMedID
15592656
Department(s)
Department of Medicine
Document Type
Article